Doctor profile · Federal record
Dr. JAY GHADIALI, M.D.
Rheumatology Physician (CMS: RHEUMATOLOGY) · Internal Medicine Physician · PHILADELPHIA, PA
- NPI 1053760835
- Accepts Medicare
- 10 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3400 SPRUCE ST
PHILADELPHIA, PA 191044238
(215) 662-2454
Credentials & registration
- NPI registered
- June 2016 — 10 yrs on file
- Profile last updated
- February 20, 2020
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #MT210707
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053760835. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,304
Distinct HCPCS
10
Medicare allowed
$320,779
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 9,030 | 13 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 4,560 | 57 | $23 | |
J3489 |
Injection, zoledronic acid, 1 mg | 371 | 75 | $9 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 273 | 159 | $127 | |
96372 |
Injection of drug or substance under skin or into muscle | 258 | 89 | $14 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 175 | 30 | $1 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 146 | 94 | $179 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 130 | 130 | $220 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 82 | 16 | $133 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 74 | 74 | $65 |
In context: peer comparison
Among 31 peers in this city , average services per provider: 860. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$2,633
Transactions
89
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 20 | $694.87 | |
| Amgen Inc. | 11 | $246.05 | |
| AstraZeneca Pharmaceuticals LP | 5 | $204.34 | |
| Janssen Biotech, Inc. | 5 | $189.26 | |
| Genentech USA, Inc. | 7 | $165.36 | |
| Fresenius Kabi USA, LLC | 9 | $137.80 | |
| UCB, Inc. | 7 | $133.77 | |
| Lilly USA, LLC | 4 | $97.06 | |
| PFIZER INC. | 4 | $96.80 | |
| ANI Pharmaceuticals, Inc. | 4 | $81.95 | |
| Organon Llc | 3 | $80.93 | |
| Sandoz Inc. | 4 | $76.28 | |
| Alexion Pharmaceuticals, Inc. | 2 | $68.31 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $59.06 | |
| Novartis Pharmaceuticals Corporation | 2 | $51.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
765
Patients
246
Total drug cost
$18,994
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 320 | 83 | $2,864 |
| Methotrexate (Methotrexate Sodium) | Brand | 108 | 47 | $4,365 |
| Alendronate Sodium | Generic | 71 | 23 | $1,000 |
| Hydroxychloroquine Sulfate | Generic | 70 | 33 | $6,157 |
| Allopurinol | Generic | 67 | 17 | $1,170 |
| Meloxicam | Generic | 28 | 15 | $174 |
| Methylprednisolone | Generic | 24 | 17 | $200 |
| Colchicine | Generic | 21 | 0 | $1,744 |
| Tramadol Hcl | Generic | 19 | 0 | $169 |
| Leflunomide | Generic | 13 | 11 | $587 |